InvestSMART

Anteris Technologies Ltd (ASX: AVR) - Announcements

Current share price for AVR : $11.750 0.07 (0.60%)+

ASX company news and announcements for Anteris Technologies Ltd (AVR) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Anteris Technologies Ltd (AVR) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Anteris Technologies Ltd (AVR), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Anteris Technologies Ltd (AVR)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$1,145 Becoming a substantial holder from MUFG 12 Apr 2023 8:15AM $22.500 $11.750 fallen by 47.78%
$1,145 Ceasing to be a substantial holder from MUFG 11 Apr 2023 6:28PM $22.500 $11.750 fallen by 47.78%
$1,145 Becoming a substantial holder for MS 11 Apr 2023 8:24AM $21.500 $11.750 fallen by 45.35%
$1,145 Ceasing to be a substantial holder from MS 11 Apr 2023 8:22AM $21.500 $11.750 fallen by 45.35%
$1,145 Becoming a substantial holder from MUFG 4 Apr 2023 7:23PM $19.750 $11.750 fallen by 40.51%
$1,145 Becoming a substantial holder from MS 4 Apr 2023 8:05AM $20.000 $11.750 fallen by 41.25%
$1,145 Becoming a substantial holder 3 Apr 2023 4:37PM $20.000 $11.750 fallen by 41.25%
$1,145 FDA Allows Manufacturing to Begin at Expanded Facility 27 Mar 2023 9:50AM $18.500 $11.750 fallen by 36.49%
$1,145 Presentation at NWR Virtual Healthcare Conference 21 Mar 2023 9:34AM $18.690 $11.750 fallen by 37.13%
$1,145 Application for quotation of securities - AVR 20 Mar 2023 6:45PM $18.690 $11.750 fallen by 37.13%
$1,145 NWR Virtual Healthcare Conference 20 Mar 2023 10:33AM $18.890 $11.750 fallen by 37.80%
$1,145 Notice of AGM Date and Closing of Nominations for Directors 20 Mar 2023 10:32AM $18.890 $11.750 fallen by 37.80%
$1,145 S&P DJI Announces March 2023 Quarterly Rebalance 3 Mar 2023 5:03PM $21.770 $11.750 fallen by 46.03%
$1,145 Preliminary Final Report 28 Feb 2023 1:20PM $22.090 $11.750 fallen by 46.81%
$1,145 Notification of cessation of securities - AVR 27 Feb 2023 9:45AM $21.710 $11.750 fallen by 45.88%
$1,145 Cleansing Notice 15 Feb 2023 12:48PM $21.970 $11.750 fallen by 46.52%
$1,145 Notification regarding unquoted securities - AVR 15 Feb 2023 12:41PM $21.970 $11.750 fallen by 46.52%
$1,145 Application for quotation of securities - AVR 15 Feb 2023 11:00AM $21.600 $11.750 fallen by 45.60%
$1,145 Settlement of $35M Capital Raising Transaction 15 Feb 2023 10:46AM $21.100 $11.750 fallen by 44.31%
$1,145 Change in substantial holding 14 Feb 2023 6:14PM $22.100 $11.750 fallen by 46.83%
$1,145 Notification of cessation of securities - AVR 10 Feb 2023 1:23PM $23.000 $11.750 fallen by 48.91%
$1,145 FDA Grants Expanded Approval for the DurAVR EFS 9 Feb 2023 9:53AM $24.040 $11.750 fallen by 51.12%
$1,145 Proposed issue of securities - AVR 9 Feb 2023 9:53AM $24.040 $11.750 fallen by 51.12%
$1,145 $35M Capital Raise 9 Feb 2023 9:52AM $24.040 $11.750 fallen by 51.12%
$1,145 Trading Halt 7 Feb 2023 10:04AM $24.040 $11.750 fallen by 51.12%

401 - 425 of 713 results

Page 17 of 29

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.